Millennium Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Sell |
248,087
-1,128,634
| -82% | -$2.72M | ﹤0.01% | 3275 |
|
|
2025
Q1 | $3.04M | Sell |
1,376,721
-530,540
| -28% | -$1.17M | ﹤0.01% | 2312 |
|
|
2024
Q4 | $10.4M | Sell |
1,907,261
-2,418,051
| -56% | -$13.2M | 0.01% | 1541 |
|
|
2024
Q3 | $35.9M | Sell |
4,325,312
-1,643,280
| -28% | -$13.7M | 0.02% | 752 |
|
|
2024
Q2 | $42.7M | Buy |
5,968,592
+713,639
| +14% | +$5.11M | 0.02% | 633 |
|
|
2024
Q1 | $45.6M | Sell |
5,254,953
-531,896
| -9% | -$4.61M | 0.02% | 587 |
|
|
2023
Q4 | $37.9M | Buy |
5,786,849
+1,524,650
| +36% | +$9.99M | 0.02% | 648 |
|
|
2023
Q3 | $42.6M | Buy |
4,262,199
+4,040,786
| +1,825% | +$40.4M | 0.02% | 523 |
|
|
2023
Q2 | $2.75M | Buy |
221,413
+211,020
| +2,030% | +$2.62M | ﹤0.01% | 2321 |
|
|
2023
Q1 | $146K | Sell |
10,393
-2,585,155
| -100% | -$36.3M | ﹤0.01% | 3956 |
|
|
2022
Q4 | $37.1M | Buy |
2,595,548
+799,274
| +44% | +$11.4M | 0.02% | 630 |
|
|
2022
Q3 | $45.9M | Buy |
1,796,274
+1,687,021
| +1,544% | +$43.1M | 0.03% | 457 |
|
|
2022
Q2 | $3.1M | Sell |
109,253
-555,426
| -84% | -$15.8M | ﹤0.01% | 2532 |
|
|
2022
Q1 | $23.4M | Buy |
664,679
+143,060
| +27% | +$5.05M | 0.01% | 833 |
|
|
2021
Q4 | $21.9M | Buy |
521,619
+142,869
| +38% | +$5.99M | 0.01% | 940 |
|
|
2021
Q3 | $18.6M | Buy |
378,750
+100
| +0% | +$4.91K | 0.01% | 962 |
|
|
2021
Q2 | $15.8M | Buy |
378,650
+13,045
| +4% | +$544K | 0.01% | 1015 |
|
|
2021
Q1 | $13M | Sell |
365,605
-340,093
| -48% | -$12.1M | 0.01% | 1148 |
|
|
2020
Q4 | $19.8M | Buy |
+705,698
| New | +$19.8M | 0.01% | 792 |
|